PCOS treatment is goal-led, not diagnosis-led. The same diagnosis in two different women can mean very different prescriptions — because one woman might want regular cycles and clearer skin, another wants to conceive, and a third is mostly worried about long-term diabetes risk. Indian and international guidelines (ESHRE 2023, FOGSI's PCOS consensus) start by asking what matters most to you, then build a treatment plan around that goal.

Almost every PCOS plan rests on a shared foundation: lifestyle interventions targeting insulin resistance. On top of that base, your gynaecologist or endocrinologist layers in medication choices depending on whether your priority is cycle regulation, acne and hirsutism, fertility, or metabolic protection. Some women need only the foundation; many need one or two add-ons; a few need the full stack.

Critically, PCOS is a lifelong condition. The aim is not a cure but sustained control — fewer missed cycles, calmer skin, easier weight regulation, and a lower long-term risk of type 2 diabetes, hypertension, and endometrial cancer. Reviews every six to twelve months are the norm, not the exception. For more on the day-to-day weight, hair, and mood loop, see Hair Fall, Weight & Mood – It’s Connected.

• A five to ten percent reduction in body weight, in women with overweight or obesity, restores ovulation in roughly half of cases and improves insulin sensitivity, lipid panels, and androgen levels. This is not a cosmetic target; it is a clinical one.
• Strength training two to three times a week matters as much as cardio for PCOS because muscle is the body's largest insulin sink. Indian women who add even thirty minutes of resistance work weekly often see fasting insulin numbers drop faster than from steady-state cardio alone.
• Carbohydrate quality matters more than carbohydrate quantity. Swap white rice for hand-pounded or millets, add a fist of protein and a palm of vegetables at every meal, and keep added sugar low. For a deeper dive, see Anti‑PCOS Diet – What Actually Works.
• Sleep restriction (under six hours) and chronic stress both raise insulin resistance and worsen PCOS symptoms; a regular bedtime and a brief daily wind-down ritual are not optional extras, they are treatment.
• Lifestyle is not a substitute for medication in moderate-to-severe PCOS, but it amplifies every other treatment. Women who maintain the foundation typically need lower doses of metformin or inositol and report fewer side effects.

Metformin (brand names Glycomet, Obimet, Glyciphage in India) is the most prescribed PCOS medication in the country. It is technically a type 2 diabetes drug, but it works in PCOS by lowering insulin resistance — the underlying engine that drives androgen excess, irregular cycles, and weight gain.

Typical starting doses are 500 mg once daily with the largest meal, titrated up over two to four weeks to 1500 mg to 2000 mg in divided doses. The slow ramp is deliberate: it minimises the gastrointestinal side effects (nausea, bloating, loose stools) that cause many women to abandon the drug in the first week. Extended-release versions (Glycomet SR, Glyciphage SR) are gentler on the gut and worth asking about if standard metformin upsets your stomach.

Cost in India is among the lowest of any chronic medication: a month's supply runs roughly fifty to three hundred rupees. Most generic versions are bioequivalent; brand choice is rarely clinically significant.

Metformin causes only modest weight loss on its own (typically two to four kilograms over six to twelve months) — the popular belief that it is a weight-loss drug is overstated. Its real value is restoring ovulation in some women, improving cycle regularity, and lowering the long-term risk of progressing to type 2 diabetes. Long-term use can deplete vitamin B12, so an annual B12 level is now considered standard of care.

Metformin is generally safe in pregnancy and is often continued through the first trimester in women who conceived on it; this decision is individualised and should be reviewed with your OB-GYN.

Inositol is a B-vitamin-like compound that, in two specific forms — myo-inositol and d-chiro-inositol — helps the body use insulin more efficiently. Multiple randomised trials and a 2023 Cochrane review suggest it can improve menstrual regularity, ovulation, and metabolic markers in PCOS, with a side-effect profile far gentler than metformin.

The form that matters most is a 40 to 1 ratio of myo-inositol to d-chiro-inositol, mirroring the natural proportion in healthy ovaries. Indian brands that supply this exact ratio include Inofolic Alpha, PCOSofy, Velositol, and OvaBless; expect to pay roughly five hundred to fifteen hundred rupees a month. Cheaper single-form myo-inositol powders work less reliably and are not recommended as a first choice.

Typical dosing is two grams of myo-inositol plus fifty milligrams of d-chiro-inositol, twice a day, taken with meals. Most women begin to notice cycle changes by month three; give it at least six months before judging the response.

Inositol pairs well with metformin and lifestyle and is often used as a metformin alternative in women who cannot tolerate the gastrointestinal side effects of metformin, or who want a gentler first step. It is also commonly prescribed during fertility preparation, including before IVF cycles, because of its small but consistent benefit on egg quality.

Inositol is not a quick fix and is not a substitute for medical care in severe insulin resistance, but for mild to moderate PCOS it is a credible, well-tolerated tool that has earned its place on the ladder.

• Combined oral contraceptive pills (OCPs) remain the most reliable medical tool for restoring predictable monthly bleeds and calming androgen-driven acne and hirsutism. They work by suppressing the abnormal hormonal signalling from the brain and lowering free testosterone in circulation.
• Indian OB-GYNs commonly prescribe Krimson 35 (cyproterone acetate plus ethinyl estradiol), Yaz or Yasmin (drospirenone plus ethinyl estradiol), and Diane 35 (cyproterone acetate plus ethinyl estradiol). Krimson 35 and Diane 35 have the strongest anti-androgen effect and are often chosen when acne or facial hair is the dominant complaint. Costs typically run two hundred to eight hundred rupees a month.
• Beyond cycle regulation, OCPs protect the endometrium. Women with PCOS who go many months without a period accumulate a thickened uterine lining, which raises the long-term risk of endometrial hyperplasia and cancer. A scheduled monthly withdrawal bleed on the pill resets the lining.
• OCPs are not for everyone. Contraindications include a personal or strong family history of clots, uncontrolled hypertension, migraine with aura, active liver disease, and smoking over age thirty-five. Always disclose your full history at the consultation.
• If combined pills are not an option, a progesterone-only approach (oral progestin for ten days every one to three months, or a hormonal IUD like Mirena) can provide endometrial protection without the estrogen exposure.
• OCPs do not cure PCOS; they manage its symptoms while you take them. The underlying hormonal pattern returns within weeks of stopping, which is why they are usually layered with the lifestyle foundation, not used as a standalone fix.

Spironolactone is the most commonly prescribed anti-androgen in India for PCOS-related acne, hirsutism, and scalp hair thinning. Originally a blood-pressure drug, at PCOS doses (50 mg to 100 mg twice daily) it blocks androgen receptors in skin and hair follicles. Cost runs roughly two hundred to five hundred rupees a month for generic versions.

Visible improvement takes time: most women see meaningful change in acne by month three and in hirsutism by month six to nine. Patience is part of the prescription. Spironolactone is often combined with an OCP, both to multiply the anti-androgen effect and to guarantee contraception, because spironolactone can cause feminisation of a male foetus if pregnancy occurs while taking it. Reliable contraception is non-negotiable.

Finasteride (1 mg or 2.5 mg daily) is used off-label in India for severe scalp hair loss or hirsutism that does not respond to spironolactone. It carries the same pregnancy contraindication and is usually started by a dermatologist or endocrinologist rather than a general gynaecologist.

Topical eflornithine cream (Vaniqa, where available) slows facial hair regrowth and is often layered with laser hair reduction or intense pulsed light treatment for visible results within six months.

Anti-androgens are not appropriate if you are actively trying to conceive; in that situation the conversation shifts to ovulation induction instead. They are also not first-line for mild cosmetic concerns where lifestyle and an OCP may be enough.

• Letrozole (Femara, Letoval, brand cost two hundred to six hundred rupees per cycle) is now the first-line drug for ovulation induction in PCOS, after a landmark 2014 trial and the 2018 and 2023 ESHRE updates showed it produces higher live-birth rates than clomiphene citrate.
• Clomiphene citrate (Clomid, Fertomid, around one hundred to three hundred rupees per cycle) remains widely used in India, particularly at smaller centres, and is still a reasonable second-line option when letrozole is unavailable or has failed.
• Metformin is often added to ovulation induction, especially in women with significant insulin resistance or a high BMI, as it modestly improves ovulation and reduces the risk of ovarian hyperstimulation.
• If three to six cycles of oral ovulation induction do not result in pregnancy, the next step is typically gonadotropin injections combined with intrauterine insemination (IUI). This is more expensive (eight thousand to thirty thousand rupees per cycle in private Indian clinics) and requires close monitoring.
• In vitro fertilisation (IVF) is the final step for women who do not respond to oral or injectable ovulation induction, or who have additional fertility factors. A single IVF cycle in India typically costs one and a half to three lakh rupees; PCOS responds well to IVF but carries a higher risk of ovarian hyperstimulation, so protocols are usually adjusted.
• Before starting any TTC treatment, basic groundwork helps: see Trying to Conceive 101: Your Comprehensive Guide for the pre-conception check-list, including thyroid, vitamin D, and a partner sperm analysis.

Bariatric surgery (most commonly sleeve gastrectomy in India) is considered in women with PCOS and a BMI above thirty-five with at least one significant metabolic complication — type 2 diabetes, severe sleep apnoea, fatty liver disease, or treatment-resistant hypertension. For Indian populations, some specialists use a slightly lower BMI threshold of thirty-two to thirty-three because Indians develop metabolic disease at lower body weights than Western populations.

The metabolic improvements are striking: ovulation often returns within months, insulin resistance drops dramatically, and many women either come off PCOS medication entirely or significantly reduce their doses. Fertility frequently returns even without further intervention.

In India, sleeve gastrectomy in a reputable private hospital typically costs two to four lakh rupees; gastric bypass is more expensive. Many insurance plans now cover bariatric surgery when metabolic indications are documented.

Surgery is not a shortcut. It requires lifelong follow-up — micronutrient supplementation, dietary changes, and routine bloodwork — and is preceded by months of evaluation by a multidisciplinary team. Pregnancy is typically discouraged for the first twelve to eighteen months after surgery while weight stabilises.

Bariatric surgery is not a fit for everyone, and it is rarely the first conversation a gynaecologist will have with you. It belongs on the menu, but well down the ladder, after lifestyle, medication, and a sober conversation about long-term metabolic risk.

Depression and anxiety occur at two to three times the rate in women with PCOS compared to the general population — a finding consistent in Indian studies as well. Some of this is hormonal; much of it is the cumulative weight of cycle unpredictability, acne, weight struggles, and the social pressure that lands disproportionately on women in India.

Treating the mental health side is part of treating PCOS, not a side quest. Screening for depression and anxiety should happen at every annual review; if you are struggling, name it during the consultation rather than waiting to be asked.

Talk therapy (CBT in particular) has strong evidence in PCOS for reducing depressive symptoms and improving body image. SSRIs (commonly sertraline, escitalopram, fluoxetine in India) are safe and effective when therapy alone is not enough. A psychiatrist consultation in a metro typically costs eight hundred to two thousand rupees; many tele-mental-health services now offer this at lower cost.

Peer support — online PCOS communities, in-person groups, or a sister or friend who lives with it too — repeatedly comes up in Indian patient surveys as one of the most protective factors against burnout and despair.

If acne, hirsutism, or weight changes are eroding your sense of self, that is a clinical concern, not a vanity one. A combined plan that addresses both the physical and the emotional load is more sustainable than treating one and ignoring the other.

Many Indian women weave Ayurvedic herbs and practices into their PCOS care, and a respectful, evidence-based view recognises both the genuine benefits and the real limits of this approach.

Specific herbs with reasonable supporting evidence in PCOS include cinnamon (improves insulin sensitivity), fenugreek seed extract (modest improvements in cycle regularity), and spearmint tea (small but measurable reduction in androgen levels and hirsutism). Yoga, particularly regular practice of suryanamaskar and supta baddha konasana, has been shown in Indian trials to improve cycle frequency and reduce stress markers.

The limits are equally important. No Ayurvedic protocol has been shown to replace metformin, inositol, or letrozole for moderate-to-severe PCOS. Be cautious of clinics promising a complete cure in three months, especially those that combine herbal mixes with unlabelled hormones or steroids — these have caused real harm in Indian patient reports.

The best practice is integration, not substitution: keep your gynaecologist or endocrinologist as the primary lead, and add Ayurvedic or yoga elements that complement rather than replace medical treatment. Tell both sides what the other has prescribed; herb-drug interactions are real, especially with metformin and the OCP.

For a deeper, balanced view, see Ayurveda for PCOS: Holistic Balance & Hormonal Harmony.

• Fasting glucose, HbA1c, and ideally a fasting insulin level once a year. Indian women with PCOS have a substantially elevated lifetime risk of type 2 diabetes, and early detection allows for early intervention.
• Lipid profile (total cholesterol, LDL, HDL, triglycerides) once a year, more often if already abnormal.
• Blood pressure at every clinic visit. Hypertension risk is higher in PCOS independent of weight.
• Endometrial review: if you go more than three to four months without a period, your gynaecologist may order a pelvic ultrasound to check endometrial thickness, especially after age thirty.
• Vitamin B12 annually if you are on long-term metformin; vitamin D once a year for all women given India's widespread deficiency.
• Mental health screen at each annual review, with low threshold for referral to a psychologist or psychiatrist.
• Annual review of the full medication list — what is still needed, what can be tapered, whether life goals (TTC plans, weight changes) call for a different combination.

• For complex PCOS — severe insulin resistance, treatment-resistant cycles, or significant mental health overlap — an endocrinologist or a women's-health-trained internist is often a better lead than a general gynaecologist. In metros, a combined OB-GYN plus endocrinology team gives the most comprehensive care.
• In smaller towns, the first-line specialist will be a general OB-GYN, who can manage most PCOS cases well. Ask for a referral if your symptoms are not improving after six months on a stable regimen.
• Myth: weight loss alone fixes PCOS. Mostly true in mild cases with overweight, but many lean women have PCOS too, and medication or supplements are often still needed even after weight goals are met.
• Myth: PCOS treatment is only relevant if you are trying to conceive. False. Cycle regulation, endometrial protection, metabolic monitoring, and acne or hirsutism treatment are all important regardless of fertility plans.
• Myth: metformin is a weight-loss drug. Mostly false. Metformin's weight effect is modest; lifestyle plus strength training is the engine of weight change, with metformin as an enabling cofactor.
• Myth: there is one definitive PCOS test. False. Diagnosis uses the Rotterdam criteria — at least two of three among irregular cycles, clinical or biochemical androgen excess, and polycystic ovaries on ultrasound. There is no single blood test that confirms or rules out PCOS.
• Government and large private hospitals often run subsidised PCOS clinics; ask at the OB-GYN OPD or check your local district hospital website. Telemedicine consultations have made specialist access much easier in tier 2 and tier 3 cities since 2020.

• Name your top one or two priorities for this year — cycle regularity, clearer skin, lower diabetes risk, fertility — and bring that to your next OB-GYN appointment as the anchor of the conversation.
• Confirm the lifestyle foundation is in place: strength training twice a week, an honest look at sleep and stress, and a meal pattern your dietitian or gynaecologist endorses. The medications work better when the foundation is solid.
• Ask explicitly about metformin or inositol if you have insulin resistance signs (acanthosis nigricans, central weight gain, family diabetes history); ask about OCPs if cycles or acne are the main complaint; ask about anti-androgens if hirsutism is the main complaint.
• Book the annual labs above on a single morning to make it easy to remember; many private labs in India bundle these as a PCOS panel for one to two thousand rupees.
• Build a small support layer: one friend who knows, one online community you trust, and a therapist on call if mood dips. PCOS is a marathon, and the people around you are part of the treatment plan.